The most recent trading session ended with AbbVie (NYSE: ABBV) standing at $169.91, reflecting a +1.05% shift from the previouse trading day's closing. The stock outperformed the S&P 500, which registered a daily loss of 0.88%. Elsewhere, the Dow saw an upswing of 0.08%, while the tech-heavy Nasdaq depreciated by 1.95%. The drugmaker's stock has climbed by 1.23% in the past month, exceeding the Medical sector's loss of 1.09% and lagging the S&P 500's gain of 5.11%. Investors will be eagerly watching for the performance of AbbVie in its upcoming earnings disclosure. The company's earnings report is set to be unveiled on July 25, 2024. The company is expected to report EPS of $3.02, up 3.78% from the prior-year quarter. Meanwhile, our latest consensus estimate is calling for revenue of $14.04 billion, up 1.29% from the prior-year quarter. For the annual period, ...